Therapeutic Approach

Archive: September, 2014

Ritter Pharmaceuticals Names Michael D. Step Chief Executive Officer

LOS ANGELES (September 30, 2014) – Ritter Pharmaceuticals, Inc., a privately held pharmaceutical company focused on gastrointestinal disorders, announced  today that Michael D. Step has been named chief executive officer, effective October 1, 2014.  Mr. Step was appointed to the company’s board of directors in 2011 and will continue to serve as a director.  Andrew […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD